- Filed
- Nov 28, 2023 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · Nov 16, 2023 | 168.5M sh |
| Shares Diluted | Q3 2024 · Oct 31, 2023 | 185.98M sh |
| Shares Diluted | Q3 2024 · Oct 31, 2023 | 166.47M sh |
| Shares Diluted | Q3 2024 · Oct 31, 2022 | 163.04M sh |
| Shares Diluted | Q3 2024 · Oct 31, 2022 | 161.74M sh |
| Capex | Q3 2024 · Oct 31, 2023 | $9.19M |
| Capex | Q3 2024 · Oct 31, 2022 | $9.23M |
| Operating Cash Flow | Q3 2024 · Oct 31, 2023 | $587.02M |
| Operating Cash Flow | Q3 2024 · Oct 31, 2022 | $173.64M |
| Short Term Debt | Q3 2024 · Oct 31, 2023 | $0 |
| Short Term Debt | Q3 2024 · Jan 31, 2023 | $775.66M |
| Short Term Investments | Q3 2024 · Oct 31, 2023 | $761.75M |
| Short Term Investments | Q3 2024 · Jan 31, 2023 | $1.32B |
| Cash And Equivalents | Q3 2024 · Oct 31, 2023 | $927.96M |
| Cash And Equivalents | Q3 2024 · Jan 31, 2023 | $690.59M |
| Stockholders Equity | Q3 2024 · Oct 31, 2023 | $198.89M |
| Stockholders Equity | Q3 2024 · Jan 31, 2023 | −$110.51M |
| Stockholders Equity | Q3 2024 · Oct 31, 2022 | −$569.65M |
| Current Liabilities | Q3 2024 · Oct 31, 2023 | $1.82B |
| Current Liabilities | Q3 2024 · Jan 31, 2023 | $3.04B |
| Total Liabilities | Q3 2024 · Oct 31, 2023 | $5.19B |
| Total Liabilities | Q3 2024 · Jan 31, 2023 | $6.45B |
| Current Assets | Q3 2024 · Oct 31, 2023 | $3.08B |
| Current Assets | Q3 2024 · Jan 31, 2023 | $3.87B |
| Total Assets | Q3 2024 · Oct 31, 2023 | $5.39B |
| Total Assets | Q3 2024 · Jan 31, 2023 | $6.34B |
| Eps Diluted | Q3 2024 · Oct 31, 2023 | $0.55 |
| Eps Diluted | Q3 2024 · Oct 31, 2023 | −$0.98 |
| Eps Diluted | Q3 2024 · Oct 31, 2022 | −$0.20 |
| Eps Diluted | Q3 2024 · Oct 31, 2022 | −$3.38 |
| Eps Basic | Q3 2024 · Oct 31, 2023 | $0.58 |
| Eps Basic | Q3 2024 · Oct 31, 2023 | −$0.98 |
| Eps Basic | Q3 2024 · Oct 31, 2022 | −$0.20 |
| Eps Basic | Q3 2024 · Oct 31, 2022 | −$3.38 |
| Sga Expense | Q3 2024 · Oct 31, 2023 | $138.49M |
| Sga Expense | Q3 2024 · Oct 31, 2023 | $352.33M |
| Sga Expense | Q3 2024 · Oct 31, 2022 | $118.31M |
| Sga Expense | Q3 2024 · Oct 31, 2022 | $345.4M |
| Rd Expense | Q3 2024 · Oct 31, 2023 | $232.54M |
| Rd Expense | Q3 2024 · Oct 31, 2023 | $708.59M |
| Rd Expense | Q3 2024 · Oct 31, 2022 | $241.4M |
| Rd Expense | Q3 2024 · Oct 31, 2022 | $754.14M |
| Operating Income | Q3 2024 · Oct 31, 2023 | $82.77M |
| Operating Income | Q3 2024 · Oct 31, 2023 | −$192.31M |
| Operating Income | Q3 2024 · Oct 31, 2022 | −$19.79M |
| Operating Income | Q3 2024 · Oct 31, 2022 | −$501.58M |
| Gross Profit | Q3 2024 · Oct 31, 2023 | $857.38M |
| Gross Profit | Q3 2024 · Oct 31, 2023 | $2.1B |
| Gross Profit | Q3 2024 · Oct 31, 2022 | $728M |
| Gross Profit | Q3 2024 · Oct 31, 2022 | $1.79B |
| Cost Of Revenue | Q3 2024 · Oct 31, 2023 | $209.97M |
| Cost Of Revenue | Q3 2024 · Oct 31, 2023 | $629.11M |
| Cost Of Revenue | Q3 2024 · Oct 31, 2022 | $201.77M |
| Cost Of Revenue | Q3 2024 · Oct 31, 2022 | $610.71M |
| Revenue | Q3 2024 · Oct 31, 2023 | $1.07B |
| Revenue | Q3 2024 · Oct 31, 2023 | $2.73B |
| Revenue | Q3 2024 · Oct 31, 2022 | $929.77M |
| Revenue | Q3 2024 · Oct 31, 2022 | $2.4B |